Trillium Therapeutics Announces Pricing of Public Offering of Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
UPDATE: Trillium Therapeutics (TRIL) Prices 1.52M Common Offering at $19.50/Share
April 1, 2015 7:01 AM EDT(Updated - April 1, 2015 7:03 AM EDT)
Trillium Therapeutics (NASDAQ: TRIL) has priced a 1.52 million common stock offering at $19.50 per share.
UPDATE - The press release and SEC filing follow:
Trillium Therapeutics announced that it has priced an underwritten public offering of 1,522,395 common... More
